DS

Denise Scots-knight

Chief Executive Officer and Founder at Mereo Biopharma Group plc and Non-Executive Board Member

United Kingdom

Overview 

Denise Scots-Knight is the Chief Executive Officer and Founder of Mereo Biopharma Group plc, with a background in corporate development, private equity, and business strategy. She has held key roles at Elanco as a Non-Executive Board Member and Phase4 Partners as Managing Partner, showcasing her expertise in biopharmaceuticals and strategic planning.

Work Experience 

E

Elanco

  • Non Executive Board Member

    2019 - Current

Elanco develops, manufactures and markets products for companion and food animals.

Raised $252,860,000.00 from Ancora.

elanco.com
MB

Mereo BioPharma

  • Chief Executive Officer

    2015

PP

Phase4 Partners

  • Managing Partner

    2010 - 2015

    Board member Nabriva Therapeutics, Albireo, Oncomed and Idenix Pharmaceuticals

BH

British Heart Foundation

  • Trustee and Member of the Council

    2005 - 2012

    Board member of this non-for-profit organisation and member of the Nominating and Corporate Governance Committee

Nomura Phase4 Ventures

  • Managing Director

    1999 - 2010

RA

Rothschild Asset Management

  • Investment Manager

    1997 - 1999

Education 

Articles About Denise

Relevant Websites